Heather Bresch

Biography

 Heather Bresch is chief executive officer of Mylan, one of the world’s leading pharmaceutical companies. She also serves on the company’s board of directors. As CEO, she is responsible for a workforce of more than 35,000, a powerful global research and development platform, a manufacturing footprint comprising more than 50 facilities, and a portfolio of more than 7,500 generic and branded pharmaceuticals sold in more than 165 countries and territories. Throughout her 25-year career with Mylan, Bresch, who started with the company as a data-entry clerk, has held roles of increasing responsibility in more than 15 functional areas. Prior to becoming CEO, Bresch served as Mylan’s president, where she was responsible for the day-to-day operations of the company. Before that, she served as Mylan’s chief operating officer and chief integration officer, leading the successful integration of two international acquisitions – Matrix Laboratories and Merck KGaA’s generics business – which more than doubled the size of the company and transformed Mylan from a purely U.S. company to a global one.As CEO, Bresch is leading the next chapter of Mylan’s growth and performance, and further differentiating the company from its competitors by transforming it from a pharmaceutical company into a healthcare company. This strategy includes plans to double the size of Mylan’s product portfolio, manufacturing capacity and adjusted earnings between 2012 and 2018, enhance its technologies and capabilities, expand its reach across geographies and commercial channels, and develop new services that further enhance Mylan’s relationship with customers and patients.  

Research Interest

 Business Development And Management